SCHEMBL29316102

SCHEMBL29316102

CCc1cnn(-c2ccc3[nH]ccc3c2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRP O00591 2/20 0.40
GABRD O14764 2/20 0.40
GABRA1 P14867 2/20 0.40
GABRB1 P18505 2/20 0.40
GABRG2 P18507 2/20 0.40
GABRB3 P28472 2/20 0.40
GABRA5 P31644 2/20 0.40
GABRA3 P34903 2/20 0.40
GABRA2 P47869 2/20 0.40
GABRB2 P47870 2/20 0.40
GABRA4 P48169 2/20 0.40
GABRE P78334 2/20 0.40
GABRA6 Q16445 2/20 0.40
GABRG1 Q8N1C3 2/20 0.40
GABRG3 Q99928 2/20 0.40
GABRQ Q9UN88 2/20 0.40
KDR P35968 3/20 0.37
MAOA P21397 1/20 0.36
JAK2 O60674 1/20 0.36
ROCK2 O75116 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29823492 0.81 CYP17A1 (0.46) GSK3BLRRK2MAP3K11CYP17A1CYP11B1
SCHEMBL1647063 0.78 MAOA (0.50) KDRMAOAJAK2
SCHEMBL13255925 0.74 CYP2A6 (0.41) DRD2DRD4CYP2A6ALOX15
SCHEMBL16789150 0.72 MPO (0.39) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL29316090 0.72 GABRP (0.44) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL763201 0.71 AHR (0.50) MAOACYP17A1CYP11B1CYP11B2KDM1A
SCHEMBL29445647 0.71 AHR (0.50) MAOACYP17A1CYP11B1CYP11B2KDM1A
SCHEMBL16062853 0.71 RXRA (0.47) DRD2DRD4DRD3ALOX15NPSR1
SCHEMBL17011992 0.70 NOTUM (0.47) DRD2DRD4DRD3GAAALOX15
SCHEMBL18599998 0.70 BRD9 (0.45) DRD2DRD4DRD3GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239768-A1 METHOD FOR PREPARING XANTHINE OXIDASE INHIBITOR LG CHEM, LTD. (KR) 2024-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239768-A1 METHOD FOR PREPARING XANTHINE OXIDASE INHIBITOR XDH, AOX1, PNPO GABRP 2905/4885GABRD 2525/4885GABRA1 2161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.